Difficulty: Medium
Average Score: 68%
Practice
As part of a treatment plan for patients with leukemia, a bone marrow transplant may be performed. What increased risk will these patients have post-transplant?
Correct answer
C
Rationale
In patients with leukemia undergoing a bone marrow transplant, the increased risk post-transplant is infection (Option C). This is due to the fact that the transplant procedure itself can weaken the patient's immune system, making them more susceptible to infections. Additionally, the high-dose chemotherapy and radiation used in preparation for the transplant can further compromise the immune system.
Option A, bleeding, is less likely to be a significant risk post-transplant because patients receive blood products to support their clotting function. Option B, clot formation, is also less of a concern as patients are often on medications to prevent excessive clotting.
Option D, nausea and vomiting, may occur post-transplant due to the side effects of the treatment but is not the primary increased risk. Understanding these risks is crucial in the field of hematology oncology as it helps healthcare providers anticipate and manage potential complications in leukemia patients undergoing bone marrow transplants.
Option A, bleeding, is less likely to be a significant risk post-transplant because patients receive blood products to support their clotting function. Option B, clot formation, is also less of a concern as patients are often on medications to prevent excessive clotting.
Option D, nausea and vomiting, may occur post-transplant due to the side effects of the treatment but is not the primary increased risk. Understanding these risks is crucial in the field of hematology oncology as it helps healthcare providers anticipate and manage potential complications in leukemia patients undergoing bone marrow transplants.